Durvalumab (D) and PET-directed chemoradiation (CRT) after induction FOLFOX for esophageal adenocarcinoma.
暂无分享，去创建一个
David R. Jones | S. Sihag | Laura H. Tang | Y. Janjigian | G. Ku | A. Wu | Bernard J Park | D. Ilson | S. Chalasani | D. Molena | P. Gu | M. Shcherba | S. Maron | R. Sugarman | Lara Feder | J. Norris | Kendall Cowie | Valerie Johnson